Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REvascularization RateS and Clinical OUtcomes With DABRA Laser. A Long-Term 2-year Study (RESULTS)

NCT04010045 is registered in ClinicalTrials.gov with Ra Medical Systems as lead sponsor.

NCT NCT04010045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04010045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REvascularization RateS and Clinical OUtcomes With DABRA Laser. A Long-Term 2-year Study (RESULTS)
Lead sponsor
Ra Medical Systems
Phase
Observational
Overall status
Terminated
Start date
May 2, 2019
Completion date
October 15, 2020
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral artery disease